Arlene Linetzky

Owner at Inspire

Arlene Linetzky's Professional Contact Details

Email (Verified)

****@inspirepharm.com

Get Email Address

Location

New York, New York, US

Company

Inspire

Person Seniority

owner

Arlene Linetzky's Current Company Details

Inspire

• 335 Employees

pharmaceuticals

Inspire is a biopharmaceutical company focused on researching, developing and commercializing prescription pharmaceutical products for ophthalmic and pulmonary diseases. Inspire's goal is to build and commercialize a sustainable portfolio of innovative new products based on its technical, scientific and commercial expertise. The most advanced compounds in Inspire's clinical pipeline are denufosol tetrasodium for cystic fibrosis and PROLACRIA(TM) (diquafosol tetrasodium ophthalmic solution) 2% for dry eye, which are both in Phase 3 development, and AZASITE(R) (azithromycin ophthalmic solution) 1% for blepharitis, which is in Phase 2 development. Inspire receives revenues related to the promotion of AZASITE for bacterial conjunctivitis, the co-promotion of ELESTAT(R) (epinastine HCl ophthalmic solution) 0.05% for allergic conjunctivitis and royalties based on net sales of RESTASIS(R) (cyclosporine ophthalmic emulsion) 0.05% for dry eye.

Public Symbol

ISPH

Founded Year

1995

Organization Website

inspirepharm.com

Organization Languages

English

Organization Revenue

92200

Current Technologies

nginx